Discovery of biomarker profiles in endometriosis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034713

Enrollment

150

Registered

2024-07-18

Start date

2024-03-28

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N80

Interventions

Group 1: Women without Endometriosis Two cervical and two mouth swabs are taken from each patient once Group 2: Women with deep infiltrating Endometriosis Two cervical and two mouth swabs are taken fr

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: premenopausal women over 18 confirmed/ suspected diagnosis of Endometriosis signed written consent

Exclusion criteria

Exclusion criteria: unable to provide consent current antibiotic treatment immunosuppression

Design outcomes

Primary

Measure	Time frame
RNA/DNA signatures are determined from the swabs in order to identify possible biomarkers that will facilitate the diagnosis of endometriosis in the future.	—

Secondary

Measure	Time frame
protein/ glycoproten signatures and metabolic parameters determined from the swabs in order to identify possible biomarkers that will facilitate the diagnosis of endometriosis in the future.	—

Countries

Germany

Contacts

Public ContactAndreas Wieser

Fraunhofer ITMP-IIP

andreas.wieser@itmp.fraunhofer.de+49 (0)89 2180-78296

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026